Viking Therapeutics, Inc.(股票代码:VKTX)今日盘前大涨6.18%,引发市场关注。分析人士认为,这与多家知名制药企业公开反对诺和诺德收购合同药品生产商康泰伦特有关。
据报道,罗氏、礼来、阿斯利康等制药巨头表示反对诺和诺德收购康泰伦特,称这将限制减肥药领域的竞争,不利于行业发展。作为多家公司的重要合作生产商,一旦康泰伦特被收购,其他公司在生产和供应肥胖症药物方面的竞争力可能受到削弱,包括Viking Therapeutics等小型生物科技公司。
分析人士指出,如果诺和诺德的收购案最终被阻止,将有利于维护减肥药市场的竞争环境,从而对Viking Therapeutics等公司的长远发展形成积极影响。因此,相关预期或引发Viking Therapeutics股价当日大涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.